Viewing Study NCT00180895


Ignite Creation Date: 2025-12-24 @ 1:55 PM
Ignite Modification Date: 2026-01-28 @ 8:05 PM
Study NCT ID: NCT00180895
Status: TERMINATED
Last Update Posted: 2006-09-11
First Post: 2005-09-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Burkitt Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Burkitt lymphoma View
None B-cell non Hodgkin lymphoma View
None B-cell ALL View
None Refractory View
None Relapse View
None Rituximab View
None Children View